Didanosine - Didanosine
Navigation: NDC > Supplier starting with: B > BARR LABORATORIES INC.| Field | Value |
|---|---|
| NDC Code: | 0555-0589 |
| Proprietary Name: | Didanosine |
| Suffix: | |
| Non-Proprietary Name: | Didanosine |
| Dosage Form: | CAPSULE, DELAYED RELEASE PELLETS |
| Method: | ORAL |
| Original Marketing Date: | 15-12-2004 |
| Category Name: | ANDA |
| Application Number: | ANDA077167 |
| Labeler: | BARR LABORATORIES INC. |
| Substance Name: | DIDANOSINE |
| Active Numerator Strength: | 250 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |